🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The overall aim of this study is to investigate a novel "dual instance" pla...
Status
Completed
Location
Cedars-Sinai Medical Center
Start Date
2013-01
Trial ID
NCT02024997
Treatments Being Tested
The purpose of the study is to determine the correlation between the diagno...
Status
Withdrawn
Location
Clinique Blomet
Start Date
2025-04
Trial ID
NCT06195280
Treatments Being Tested
This phase II trial tests how well giving dasatinib and quercetin with cycl...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-09-18
Trial ID
NCT06940297
This phase II trial is studying how well romidepsin works in treating patie...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center at Suffolk
Start Date
2004-10
Trial ID
NCT00098813
Treatments Being Tested
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
This phase I trial studies the side effects and best dose of genetically mo...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2015-05-18
Trial ID
NCT02208362
Treatments Being Tested
A recent pilot study, GLIMPSE (NCT02690168), was recently completed which d...
Status
Completed
Location
Pennington Biomedical Research Center
Start Date
2020-08-19
Trial ID
NCT04430660
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of ABBV-383 an...
Status
Not Yet Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-10-25
Trial ID
NCT07420959
This phase III trial compares the effect of adding cabozantinib to avelumab...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2022-06-03
Trial ID
NCT05092958
This phase II/III trial compares the effect of the combination treatment wi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-03-30
Trial ID
NCT05432791